NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch
Authors
Keywords
-
Journal
Antioxidants
Volume 10, Issue 9, Pages 1380
Publisher
MDPI AG
Online
2021-08-30
DOI
10.3390/antiox10091380
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer
- (2020) Séan M. O'Cathail et al. Cancer Genetics
- High NRF2 Levels Correlate with Poor Prognosis in Colorectal Cancer Patients and with Sensitivity to the Kinase Inhibitor AT9283 In Vitro
- (2020) Laura Torrente et al. Biomolecules
- The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase
- (2019) Viraj R. Sanghvi et al. CELL
- Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial
- (2018) E Fokas et al. ANNALS OF ONCOLOGY
- Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer
- (2018) Akhileshwar Namani et al. BMC CANCER
- NRF2 and the Hallmarks of Cancer
- (2018) Montserrat Rojo de la Vega et al. CANCER CELL
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- (2018) Francisco Sanchez-Vega et al. CELL
- The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
- (2018) Jonathan P. Evans et al. Oncotarget
- A distinct class of antioxidant response elements is consistently activated in tumors with NRF2 mutations
- (2018) Daniel C. Levings et al. Redox Biology
- Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer
- (2017) Emmanouil Fokas et al. JNCI-Journal of the National Cancer Institute
- Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
- (2017) Rodrigo Romero et al. NATURE MEDICINE
- Role of Nrf2 signaling pathway in the radiation tolerance of patients with head and neck squamous cell carcinoma: an in vivo and in vitro study
- (2017) Tao Wang et al. OncoTargets and Therapy
- Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer
- (2017) Emmanouil Fokas et al. JNCI-Journal of the National Cancer Institute
- The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review
- (2017) C. Gonzalez-Donquiles et al. PLoS One
- NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
- (2016) Iok In Christine Chio et al. CELL
- The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible
- (2016) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- The Dual Roles of NRF2 in Cancer
- (2016) Silvia Menegon et al. TRENDS IN MOLECULAR MEDICINE
- Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor
- (2016) Abigail S. Krall et al. Nature Communications
- Interaction of DNA demethylase and histone methyltransferase upregulates Nrf2 in 5-fluorouracil-resistant colon cancer cells
- (2016) Kyoung Ah Kang et al. Oncotarget
- Nrf2 promotes survival following exposure to ionizing radiation
- (2015) Konjeti R. Sekhar et al. FREE RADICAL BIOLOGY AND MEDICINE
- NRF2 regulates serine biosynthesis in non–small cell lung cancer
- (2015) Gina M DeNicola et al. NATURE GENETICS
- CFAssay: statistical analysis of the colony formation assay
- (2015) Herbert Braselmann et al. Radiation Oncology
- Dose-Response Analysis Using R
- (2015) Christian Ritz et al. PLoS One
- Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs
- (2014) Xiu Jun Wang et al. FREE RADICAL BIOLOGY AND MEDICINE
- The emerging role of the Nrf2-Keap1 signaling pathway in cancer
- (2013) M. C. Jaramillo et al. GENES & DEVELOPMENT
- STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapyin vitroandin vivo
- (2013) Melanie Spitzner et al. INTERNATIONAL JOURNAL OF CANCER
- Methylation of the KEAP1 gene promoter region in human colorectal cancer
- (2012) Naoyuki Hanada et al. BMC CANCER
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- Somatic mutations of the KEAP1 gene in common solid cancers
- (2012) Nam Jin Yoo et al. HISTOPATHOLOGY
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- Gain of Nrf2 Function in Non-Small-Cell Lung Cancer Cells Confers Radioresistance
- (2010) Anju Singh et al. ANTIOXIDANTS & REDOX SIGNALING
- Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis
- (2010) Deepti Malhotra et al. NUCLEIC ACIDS RESEARCH
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search